Skip to main content
. 2006 Aug;55(8):1131–1137. doi: 10.1136/gut.2005.079392

Table 3 Clinical response and remission: group II.

Parameter Day Placebo Fontolizumab
4 mg/kg (p value*) 10 mg/kg (p value*)
Clinical response (CDAI drop of ⩾100 points) 42 10/26 (39%) 19/32 (59%) (0.19) 20/31 (65%) (0.07)
56 9/26 (35%) 22/32 (69%) (0.02) 20/30 (67%) (0.03)
Clinical remission (CDAI ⩽150) 42 4/26 (15%) 15/32 (47%) (0.01) 14/31 (45%) (0.02)
56 7/26 (27%) 13/32 (41%) (0.41) 16/30 (53%) (0.06)

*Compared with placebo group.

CDAI, Crohn's disease activity index.